elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34218976-3FBF36C9-0F24-4F1B-BAB4-34D7963B5554
Q34218976-3FBF36C9-0F24-4F1B-BAB4-34D7963B5554
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34218976-3FBF36C9-0F24-4F1B-BAB4-34D7963B5554
The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumors
P2860
Q34218976-3FBF36C9-0F24-4F1B-BAB4-34D7963B5554
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34218976-3FBF36C9-0F24-4F1B-BAB4-34D7963B5554
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7a013020227e39eccbf6c6de8ccc37fb3c3cf7ab
P2860
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib.